Get the latest tech news

Generative AI will be designing new drugs all on its own in the near future


It won't be long for artificial intelligence can handle drug discovery for pharmaceutical companies without human scientists.

With AI able to move at a speed of discovery which in five minutes can generate as many molecules as Lilly could synthesize in an entire year in traditional wet labs, it make sense to test the limits of artificial intelligence in medicine. The top AI-generated biological designs, molecules that Rau described as having "weird-looking structures" that could not be matched to much in the company's existing molecular database, but that looked like potentially strong drug candidates, were taken to Lilly research scientists. A major precedent for AI-generated breakthroughs in biology was set in 2021 when Google's DeepMind AI, known for its creative thinking in realms ranging from the strategy game Go to music, video, and cloud computing, came up with a novel protein called AlphaFold.

Get the Android app

Or read this on r/technology

Read more on:

Photo of generative AI

generative AI

Photo of near future

near future

Photo of new drugs

new drugs

Related news:

News photo

Why RAG won’t solve generative AI’s hallucination problem

News photo

This Week in AI: Generative AI and the problem of compensating creators

News photo

AI Chatbots Have Thoroughly Infiltrated Scientific Publishing | One percent of scientific articles published in 2023 showed signs of generative AI’s potential involvement, according to a recent analysis